SecBot SecBot
424B5 ·Filed Oct 27, 2026

RAPP

Rapport Therapeutics, Inc.
NEUTRAL
Impact 3/10
Processed56m ago SEC0001193125-26-434382
Notable filing: 424B5

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001193125-26-434382
Document: 0001193125-26-434382-index-headers.html0001193125-26-434382
Document: 0001193125-26-434382-index.html0001193125-26-434382
Document: 0001193125-26-434382.txt0001193125-26-434382
24 reports for RAPP
Performance horizon
60% Hit rate @ T+60 3 of 5 directional calls Went positive at some point 7 of 9 best @ T+60▲ +24.87%Mar 10, 2026
Filters
Rows
Reports for RAPP — sortable, filterable
TypeNow
Oct 27, 2026
today
424B5
NEUTRAL ★ 3/10
$22.33awaiting T+60—$27.54 (+23.33%)
Oct 27, 2026
today
424B5
BEARISH ★ 5/10
$22.45awaiting T+60—$27.54 (−22.67%)
Oct 27, 2026
today
Press Release
BEARISH ★ 6/10
$25.80awaiting T+60—$27.54 (−6.76%)
Oct 23, 2026
4d ago
Insider Cluster
BULLISH ★ 5/10
$25.33awaiting T+60—$27.54 (+8.72%)
Oct 22, 2026
5d ago
Insider Cluster
BULLISH ★ 5/10
$25.93awaiting T+60—$27.54 (+6.21%)
Oct 20, 2026
7d ago
8-K
BULLISH ★ 7/10
$29.37awaiting T+60—$27.54 (−6.23%)
Oct 6, 2026
20d ago
144
BEARISH ★ 5/10
$30.86awaiting T+60—$27.54 (+10.76%)
Oct 1, 2026
26d ago
Insider Cluster
NEUTRAL ★ 3/10
$32.17awaiting T+60—$27.54 (−14.39%)
Aug 26, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.83awaiting T+60—$27.54 (−45.82%)
Aug 5, 2026
11w ago
8-K
MIXED ★ 5/10
$42.44awaiting T+60—$27.54 (−35.11%)
Showing 10 of 24

US Market Status

Market Closed — Opens Wed (15h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh RAPP Intelligence

Analysis is for subscribers only.

Subscribe for Full Access